秒速时时彩

  • <tr id='eqhsp'><strong id='eqhsp'></strong><small id='eqhsp'></small><button id='eqhsp'></button><li id='eqhsp'><noscript id='eqhsp'><big id='eqhsp'></big><dt id='eqhsp'></dt></noscript></li></tr><ol id='eqhsp'><option id='eqhsp'><table id='eqhsp'><blockquote id='eqhsp'><tbody id='eqhsp'></tbody></blockquote></table></option></ol><u id='eqhsp'></u><kbd id='eqhsp'><kbd id='eqhsp'></kbd></kbd>

    <code id='eqhsp'><strong id='eqhsp'></strong></code>

    <fieldset id='eqhsp'></fieldset>
          <span id='eqhsp'></span>

              <ins id='eqhsp'></ins>
                <acronym id='eqhsp'><em id='eqhsp'></em><td id='eqhsp'><div id='eqhsp'></div></td></acronym><address id='eqhsp'><big id='eqhsp'><big id='eqhsp'></big><legend id='eqhsp'></legend></big></address>

                <i id='eqhsp'><div id='eqhsp'><ins id='eqhsp'></ins></div></i>
                <i id='eqhsp'></i>
              • <dl id='eqhsp'></dl>
                1. 中文 | English
                  R&D Centre
                  About Us
                  Board of Directors
                  Milestones
                  Manufacturing facility
                  R&D Centre
                  Certification
                  Contact us
                  Supply of APIs and Formulations
                  Joint Development
                  Contract Manufacturing
                  Location
                  R&D Centre

                  1.Consist of two R&D Department (DepartmentⅠis situated in Xinchang and DepartmentⅡis situated at Zhangjiang in Shanghai)

                  2.Highly experienced team with more than 120 members

                  3.Ability to develop products and file ANDAs/dossiers in regulated markets like US, Canada, Europe, and other countries

                  4.Established Postdoctoral Scientific Research Workstation

                  5.Facilities that meet global standard

                  6、Establish good partnership for developing new drugs with Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences and Medicinal Biotech Institute, Chinese Academy of Medical Sciences, Zhejiang University, East China University of Science and Technology, Zhejiang University of Technology, University of Science and Technology of China, China Pharmaceutical University.


                  7、R&D Focusing on:Novelty and Generic drugs for anti-infective, cardiovascular and cerebrovascular diseases(hypertension, hyperlipemia, hyperglycemia,antiplatelet coagulating), central nervous system(Antidepressant, Antipsychotic, Antiparkinsonian,anti-Alzheimer's disease, Sedative-hypnotic, Anticonvulsant).

                  8、Successful case

                  Three years ago, Jingxin began Co-operation with German and British partners to develop Generic drugs(including API) , several of them have been successfully registered for marketing now. Recently, Jingxin signed an collaboration agreement with a German company, which grants Jingxin exclusive rights to develop and market a novel potential drug for insomnia in China.